依托咪酯通过miR-125b-5p介导JAK/STAT途径抑制膀胱癌细胞恶性生物学行为的机制研究OA
Study of mechanism of etomidate inhibiting the malignant biological behavior of bladder cancer cells through the JAK/STAT pathway mediated by miR-125b-5p
目的 探讨依托咪酯通过微小RNA-125b-5p(miR-125b-5p)对膀胱癌细胞的影响及其机制.方法 将BIU-87细胞分为对照组、实验组(450 mg·L-1依托咪酯培养24 h)、miR-NC组(转染miR-NC质粒,450 mg·L-1依托咪酯培养 24 h)和 miR-125b-5p 抑制剂组(转染 miR-125b-5p inhibitor 质粒,450 mg·L-1依托咪酯培养24 h).用实时荧光定量逆转录聚合酶链反应(qRT-PCR)检测各组细胞miR-125b-5p相对表达水平,用细胞计数试剂盒-8(CCK-8)检测各组细胞增殖能力,用细胞划痕法检测各组细胞的迁移能力,用Transwell法检测各组细胞的侵袭能力,用免疫荧光检测各组细胞上皮-间质转化(EMT)相关蛋白水平,用蛋白免疫印迹检测各组细胞Janus激酶2(JAK2)/信号转导与转录激活因子(STAT3)通路相关蛋白水平.结果 对照组、实验组、miR-NC组和miR-125b-5p抑制剂组的miR-125b-5p相对表达水平分别为 1.00±0.14、2.72±0.52、2.65±0.48 和 1.58±0.21,72 h 细胞增殖率分别为(100.00±12.87)%、(61.87±7.92)%、(64.58±10.92)%和(89.77±9.85)%,迁移能力分别为(68.21±7.25)%、(23.85±3.92)%、(22.67±3.58)%和(45.13±6.85)%,侵袭个数分别为(132.56±15.88)、(61.58±11.85)、(60.89±10.92)、(92.37±13.85)个,上皮-钙黏蛋白(E-cadherin)蛋白相对表达水平分别为 1.00±0.15、1.45±0.22、1.32±0.12和1.14±0.16,神经-钙黏蛋白(N-cadherin)蛋白相对表达水平分别为1.00±0.13、0.55±0.06、0.51±0.06 和 0.59±0.05,波形蛋白(Vim)蛋白相对表达水平分别为 1.00±0.16、0.48±0.08、0.51±0.05 和 0.61±0.06,磷酸化(p-)JAK2/JAK2蛋白相对表达水平分别为1.00±0.15、0.57±0.08、0.54±0.07和0.76±0.09,p-STAT3/STAT3蛋白相对表达水平分别为1.00±0.13、0.67±0.08、0.64±0.07 和 0.86±0.09.实验组的上述指标和对照组比较,miR-125b-5p抑制剂组的上述指标和miR-NC组比较,在统计学上差异均有统计学意义(P<0.05,P<0.01,P<0.001).结论 依托咪酯通过上调miR-125b-5p,抑制BIU-87细胞增殖、迁移、侵袭和EMT,可能是通过抑制JAK2/STAT3通路实现的.
Objective To investigate the effect of etomidate on bladder cancer cells through microRNA-125b-5p(miR-125b-5p)and its mechanism.Methods BIU-87 cells were divided into control group,experimental group(cultured with 450 mg·L-1 etomidate for 24 h),miR-NC group(transfected with miR-NC plasmid,cultured with 450 mg·L-1 etomidate for 24 h),miR-125b-5p inhibitor group(transfected with miR-125b-5p inhibitor plasmid,cultured with 450 mg·L-1 etomidate for 24 h).Quantitative real-time polymerase chain reaction(qRT-PCR)was used to detect the expression level of miR-125b-5p in each group of cells,cell counting kit-8(CCK-8)was utilized to evaluate the proliferative capacity of cells in each group,cell scratch assay was used to determine the migratory ability of cells in each group,Transwell assay was adopted to assess the invasive potential of cells in each group,immunofluorescence was used to detect the level of epithelial-mesenchymal transition(EMT)-related proteins in each group of cells and Western blot was used to detect the level of Janus kinase 2(JAK2)/signal transducer and activator of transcription(STAT3)pathway-related proteins in each group of cells.Results The relative expression levels of miR-125b-5p in the control group,experimental group,miR-NC group and miR-125b-5p inhibitor group were 1.00±0.14,2.72±0.52,2.65±0.48 and 1.58±0.21,respectively;the 72 h cell proliferation rate were(100.00±12.87)%,(61.87±7.92)%,(64.58±10.92)%and(89.77±9.85)%,respectively;the migration ability were(68.21±7.25)%,(23.85±3.92)%,(22.67±3.58)%and(45.13±6.85)%,respectively;the number of invasions were(132.56±15.88),(61.58±11.85),(60.89±10.92)and(92.37±13.85)cells,respectively;the relative expression levels of epithelial-cadherin(E-cadherin)protein were 1.00±0.15,1.45±0.22,1.32±0.12 and 1.14±0.16,respectively;the relative expression levels of neural-cadherin(N-cadherin)protein were 1.00±0.13,0.55±0.06,0.51±0.06 and 0.59±0.05,respectively;the relative expression levels of vimentin(Vim)protein were 1.00±0.16,0.48±0.08,0.51±0.05 and 0.61±0.06,respectively;the relative expression levels of phosphorylated(p)-JAK2/JAK2 protein were 1.00±0.15,0.57±0.08,0.54±0.07 and 0.76±0.09,respectively;the relative expression levels of p-STAT3/STAT3 protein were 1.00±0.13,0.67±0.08,0.64±0.07 and 0.86±0.09,respectively.Compared the experimental group with the control group,and compared the miR-125b-5p inhibitor group with the miR-NC group,the differences of above indicators were all statistically significant(P<0.05,P<0.01,P<0.001).Conclusion Etomidate inhibits the proliferation,migration,invasion,and EMT of BIU-87 cells by up-regulating miR-125b-5p,which may be achieved by inhibiting the JAK2/STAT3 pathway.
金文军;杨云;唐俊天;黄颖元;胡欣然;许建萍;董治龙
甘肃省武威肿瘤医院泌尿外科,甘肃武威 733000甘肃省武威肿瘤医院泌尿外科,甘肃武威 733000甘肃省武威肿瘤医院泌尿外科,甘肃武威 733000甘肃省武威肿瘤医院泌尿外科,甘肃武威 733000甘肃省武威肿瘤医院泌尿外科,甘肃武威 733000甘肃省武威肿瘤医院泌尿外科,甘肃武威 733000兰州大学第二医院泌尿外科,甘肃兰州 730030
医药卫生
依托咪酯微小RNA-125b-5p膀胱癌上皮-间质转化Janus激酶2/信号转导与转录激活因子3
etomidatemicroRNA-125b-5pbladder cancerepithelial-mesenchymal transitionJanus kinase 2/signal transducer and activator of transcription 3
《中国临床药理学杂志》 2026 (16)
2315-2321,7
武威市市级科技计划项目(WW24B01SF034)
评论